CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1, Dose-Escalation and Expansion Trial of PT2977, a HIF-2α Inhibitor, in Patients With Advanced Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02974738
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:36.714626+00:00
Published At: 2025-07-10T00:00:00+00:00
Record Updated At: 2025-07-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Advanced Solid Tumors", "Solid Tumor", "Solid Carcinoma", "Solid Tumor, Adult", "ccRCC", "RCC, Clear Cell Adenocarcinoma", "RCC", "Kidney Cancer", "Clear Cell Renal Cell Carcinoma", "Renal Cell Carcinoma, Metastatic", "Renal Cell Carcinoma Recurrent", "Renal Cell Carcinoma, Clear Cell Adenocarcinoma", "Glioblastoma", "Glioblastoma, Adult", "GBM", "Glioblastoma Multiforme"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-07-10"
protocolSection.identificationModule.nctId: "NCT02974738"
protocolSection.identificationModule.officialTitle: "A Phase 1, Dose-Escalation and Expansion Trial of PT2977, a HIF-2\u03b1 Inhibitor, in Patients With Advanced Solid Tumors"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.